New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Shorter drug treatment OK for many breast cancer patients

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo
Oncology March 06,2024
Shorter drug treatment OK for many breast cancer patients

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo
Oncology March 06,2024
Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de
Oncology March 06,2024
Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de
Oncology March 06,2024
Novel silver compounds offer a potential cancer treatment breakthrough

Novel silver compounds offer a potential cancer treatment breakthrough

by Marianne J. Cronjé And Reinout Meijboom,The ConversationOesophageal cancer cells before the silver-based compounds have been added.The development of chemotherapeutic drugs to treat various c
Oncology March 06,2024
Novel silver compounds offer a potential cancer treatment breakthrough

Novel silver compounds offer a potential cancer treatment breakthrough

by Marianne J. Cronjé And Reinout Meijboom,The ConversationOesophageal cancer cells before the silver-based compounds have been added.The development of chemotherapeutic drugs to treat various c
Oncology March 06,2024
Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys
Oncology March 06,2024
Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys
Oncology March 06,2024
Study: 'GPS' seed devices effective in localizing breast tumors

Study: 'GPS' seed devices effective in localizing breast tumors

by Tim Tedeschi,University of CincinnatiCredit: Pixabay/CC0 Public DomainUniversity of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remo
Oncology March 06,2024
Study: 'GPS' seed devices effective in localizing breast tumors

Study: 'GPS' seed devices effective in localizing breast tumors

by Tim Tedeschi,University of CincinnatiCredit: Pixabay/CC0 Public DomainUniversity of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remo
Oncology March 06,2024
Advanced ovarian cancer drug gets initial 'no' for NHS in England

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r
Oncology March 06,2024
Advanced ovarian cancer drug gets initial 'no' for NHS in England

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r
Oncology March 06,2024
Scientist identifies gene responsible for spread of prostate cancer

Scientist identifies gene responsible for spread of prostate cancer

by Caitlin Coyle,Rutgers UniversityAntonina Mitrofanova is a pioneer in the emerging field of biomedical informatics, fighting cancer with big data. Credit: Nick RomanenkoA Rutgers study has fou
Oncology March 06,2024
Scientist identifies gene responsible for spread of prostate cancer

Scientist identifies gene responsible for spread of prostate cancer

by Caitlin Coyle,Rutgers UniversityAntonina Mitrofanova is a pioneer in the emerging field of biomedical informatics, fighting cancer with big data. Credit: Nick RomanenkoA Rutgers study has fou
Oncology March 06,2024
Researcher helps define subtypes of ovarian cancer

Researcher helps define subtypes of ovarian cancer

by The City University of New YorkCredit: CC0 Public DomainIn a new paper published in the journalClinical Cancer Research, CUNY SPH Associate Professor Levi Waldron and colleagues resolved
Oncology March 06,2024
Researcher helps define subtypes of ovarian cancer

Researcher helps define subtypes of ovarian cancer

by The City University of New YorkCredit: CC0 Public DomainIn a new paper published in the journalClinical Cancer Research, CUNY SPH Associate Professor Levi Waldron and colleagues resolved
Oncology March 06,2024
Genome offers clues to esophageal cancer disparity

Genome offers clues to esophageal cancer disparity

by University of MichiganEsophagus graphic. Credit: Michigan MedicineA change in the genome of Caucasians could explain much-higher rates of the most common type of esophageal cancer in this popu
Oncology March 06,2024
Genome offers clues to esophageal cancer disparity

Genome offers clues to esophageal cancer disparity

by University of MichiganEsophagus graphic. Credit: Michigan MedicineA change in the genome of Caucasians could explain much-higher rates of the most common type of esophageal cancer in this popu
Oncology March 06,2024
Study of first birth cohort to receive HPV vaccine shows the treatment works

Study of first birth cohort to receive HPV vaccine shows the treatment works

by University of CopenhagenA tissue sample from a cervix with severe dysplasia (HSIL). Credit: University of CopenhagenCompared to a birth cohort from 1983, girls in the first birth cohort to rec
Oncology March 06,2024
Study of first birth cohort to receive HPV vaccine shows the treatment works

Study of first birth cohort to receive HPV vaccine shows the treatment works

by University of CopenhagenA tissue sample from a cervix with severe dysplasia (HSIL). Credit: University of CopenhagenCompared to a birth cohort from 1983, girls in the first birth cohort to rec
Oncology March 06,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com